Quantcast

Latest Dexmedetomidine Stories

2010-08-22 21:00:00

OSAKA, Japan, Aug. 22 /PRNewswire-FirstCall/ -- Hospira Japan Co., Ltd. today announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV(TM)200ug" (generic name: dexmedetomidine hydrochloride).

2010-07-01 07:00:00

LAKE FOREST, Ill., July 1 /PRNewswire-FirstCall/ -- Hospira, Inc.

2010-06-07 15:05:00

LAKE FOREST, Ill. , and CUPERTINO, Calif., June 7 /PRNewswire-FirstCall/ -- Hospira, Inc.

2010-04-19 08:16:00

LAKE FOREST, Ill. and CAMBRIDGE, Mass., April 19 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc.

2009-02-03 08:43:25

Nearly every patient who receives care in the intensive care unit (ICU) requires sedation. But, as researchers have discovered, not all sedation medications are equal.

2008-10-31 12:00:32

Hospira, a specialty pharmaceutical and medication delivery company, has announced that the FDA has approved a new indication for Precedex, the company's innovative drug for in-hospital sedation.

2008-10-30 12:00:21

LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for Precedex(R), the company's innovative drug for in-hospital sedation.


Word of the Day
aphotic
  • Having no light.
  • Of or relating to the region of a body of water that is not reached by sunlight and in which photosynthesis is unable to occur.
The word 'aphotic' comes from Greek roots meaning 'without' and 'light'.
Related